UW-Madison: Immuto Scientific to collaborate on novel cancer target discovery 

MADISON, Wis. ‒ University of Wisconsin–Madison and Immuto Scientific have officially entered into a collaborative agreement to identify disease-specific, novel therapeutic targets in colorectal cancer. This work will utilize Immuto’s structural surfaceomics platform, an AI-enabled analytics technology designed to discover a new, disease-specific class of therapeutic targe...